toxylact: a05ba01 arginin glutamate

The first professional lActological database in the word

Arginine glutamate (ATC A05BA01) is a liver therapy agent consisting of the amino acids arginine and glutamic acid, used mainly for functional asthenia and hepatic metabolic support, and appears compatible with breastfeeding in usual doses, although specific lactation data for this fixed combination are limited.medpedia.framar+5

Classification and pharmacological profile

Arginine glutamate belongs to the ATC group A05BA “Liver therapy”, within A05 “Bile and liver therapy”, and is designated by the code A05BA01.vidal+3
The drug is a fixed mixture/dipeptide of two proteinogenic amino acids, arginine and glutamic acid, in roughly equimolar proportion.wikipedia+1
Pharmaceutical forms include oral solutions and solutions for infusion marketed under various brand names (e.g. arginine sorbitol, Arginine Veyron) that share the same ATC level A05BA01.nature+1

Mechanism of action and indications

The preparation combines the metabolic properties of arginine and glutamic acid, supporting the urea cycle, ammonia detoxification and hepatic energy metabolism.drugbank+3
It is used in liver therapy, particularly in states of fatigue, functional asthenia, convalescence and conditions associated with hyperammonemia or increased catabolism.wikidoc+3
By providing substrates for nitric oxide synthesis and mitochondrial metabolism, arginine glutamate may improve microcirculation, reduce subjective fatigue and support hepatocyte function, although robust clinical outcome data are limited.academic.oup+3

General toxicity and safety

At therapeutic doses, arginine glutamate is usually well tolerated, but gastrointestinal adverse effects such as abdominal pain and diarrhea with fluid and electrolyte loss can occur.atcddd.fhi+1
Contraindications include biliary tract obstruction and hypersensitivity to the product or its components; caution is advised in patients with diabetes due to potential effects on glucose and insulin dynamics.onlinelibrary.wiley+2
In overdose or in patients with severe hepatic or renal impairment, excessive nitrogen load may theoretically worsen hyperammonemia or metabolic imbalance, so careful monitoring of clinical status and biochemical parameters is recommended.drugbank+2

Lactation-related considerations (toxico‑lactological)

No specific pharmacokinetic studies of arginine glutamate in breastfeeding women have been identified, but extensive experience with oral arginine suggests a high safety margin in lactation at usual supplemental doses.e-lactation+1
Arginine is naturally present in breast milk, with higher concentrations in colostrum than in mature milk, and milk composition is relatively regulated independently of maternal plasma amino acid levels, which limits transfer variability.pubmed.ncbi.nlm.nih+1
Authoritative lactation resources classify arginine as “very low risk/compatible” for breastfeeding, noting that moderate, non‑abusive oral intake up to about 3 g/day is probably harmless; similar risk is expected for arginine glutamate when used in standard therapeutic regimens for fatigue or liver therapy.synapse.patsnap+2

From a toxicological‑lactological standpoint, short‑term oral therapy with arginine glutamate at conventional doses in a healthy breastfeeding mother is unlikely to pose relevant risk to the nursing infant, provided maternal renal and hepatic function are preserved and diarrhea or significant fluid loss does not occur.medpedia.framar+3
Special caution is advisable in infants with pre‑existing metabolic disorders of the urea cycle or severe prematurity, where any increase in nitrogenous metabolites might be poorly tolerated, and in mothers receiving high‑dose parenteral amino acid therapy.sciencedirect+3
As with all amino‑acid based therapies, routine clinical observation of the breastfed infant (weight gain, feeding behavior, stool pattern) is sufficient in most cases, and discontinuation or dose adjustment should be considered if unusual symptoms appear.e-lactation+2

Dosage, monitoring and practical recommendations

Typical oral dosing described for arginine glutamate in liver therapy and functional asthenia is 2–3 ampoules of oral solution per day, administered before meals.nature+2
In breastfeeding women, it is prudent to use the lowest effective dose for the shortest necessary duration, avoiding excessive chronic supplementation above commonly recommended arginine intakes (around 3 g/day) unless clear clinical indication and supervision exist.sciencedirect+1
Breastfeeding is generally compatible with arginine glutamate therapy; however, in case of persistent maternal fatigue despite treatment, or in the presence of biliary obstruction, diabetes or significant gastrointestinal adverse effects, medical reassessment is indicated rather than unsupervised dose escalation.onlinelibrary.wiley+3

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.